BR112022018504A2 - Usos de uma composição - Google Patents
Usos de uma composiçãoInfo
- Publication number
- BR112022018504A2 BR112022018504A2 BR112022018504A BR112022018504A BR112022018504A2 BR 112022018504 A2 BR112022018504 A2 BR 112022018504A2 BR 112022018504 A BR112022018504 A BR 112022018504A BR 112022018504 A BR112022018504 A BR 112022018504A BR 112022018504 A2 BR112022018504 A2 BR 112022018504A2
- Authority
- BR
- Brazil
- Prior art keywords
- viral infections
- formula
- composition
- pharmaceutical compositions
- ace2
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 230000009385 viral infection Effects 0.000 abstract 3
- 102000053723 Angiotensin-converting enzyme 2 Human genes 0.000 abstract 1
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062990168P | 2020-03-16 | 2020-03-16 | |
| PCT/US2021/022538 WO2021188520A1 (en) | 2020-03-16 | 2021-03-16 | Method and compositions for treating, preventing or limiting the occurrence of viral infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022018504A2 true BR112022018504A2 (pt) | 2022-11-29 |
Family
ID=77768366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022018504A BR112022018504A2 (pt) | 2020-03-16 | 2021-03-16 | Usos de uma composição |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230132782A1 (https=) |
| EP (1) | EP4121040A4 (https=) |
| JP (1) | JP2023518390A (https=) |
| KR (1) | KR20230012469A (https=) |
| CN (1) | CN115397410A (https=) |
| AU (1) | AU2021236622A1 (https=) |
| BR (1) | BR112022018504A2 (https=) |
| CA (1) | CA3172162A1 (https=) |
| WO (1) | WO2021188520A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230165831A1 (en) * | 2021-11-19 | 2023-06-01 | Impact Biolife Science, Inc. | Method and composition for rendering cancer cells susceptible to treatment by targeted oncogenetic drivers |
| CN117462539A (zh) * | 2023-12-26 | 2024-01-30 | 云南中医药大学 | 一种二氢黄酮醇型化合物的抗冠状病毒用途及制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1605335A (zh) * | 2003-05-30 | 2005-04-13 | 任启生 | 含有二氢杨梅素和杨梅素的组合物用于抗病毒等药物 |
| US8034838B2 (en) * | 2008-05-29 | 2011-10-11 | Daryl Lee Thompson | Composition and method for the treatment of neurological disorders |
| CN101701245B (zh) * | 2009-10-21 | 2013-06-19 | 中国科学院生物物理研究所 | 从中药中筛选sars冠状病毒主蛋白酶抑制剂的方法 |
| US20140194500A1 (en) * | 2013-01-08 | 2014-07-10 | Kookmin University Industry Academic Cooperation Foundation | Methods For Treating of SARS |
| US10383842B2 (en) * | 2015-02-13 | 2019-08-20 | Global Biolife Inc. | Method and composition for preventing and treating viral infections |
| US12257231B2 (en) * | 2015-02-13 | 2025-03-25 | Global Biolife Inc. | Method and composition for preventing and treating viral infections |
| US10123991B2 (en) * | 2015-05-15 | 2018-11-13 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
| US10966954B2 (en) * | 2016-05-16 | 2021-04-06 | Global Biolife Inc. | Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders |
| US10987371B2 (en) * | 2017-06-09 | 2021-04-27 | Adaerata, Limited Partnership | Methods of preventing or treating filovirus and flavivirus diseases |
| WO2019045677A1 (en) * | 2017-08-28 | 2019-03-07 | Global Biolife Inc. | METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS |
| CN113350330B (zh) * | 2020-03-06 | 2023-04-14 | 中国科学院上海药物研究所 | 杨梅素类化合物在制备防治新冠肺炎药物中的应用 |
| CN112546038A (zh) * | 2020-11-19 | 2021-03-26 | 澳门科技大学 | 杨梅素在制备预防或治疗冠状病毒、流感病毒的药物中的应用 |
| CN113244217A (zh) * | 2021-06-25 | 2021-08-13 | 南开大学 | 二氢杨梅素在制备抑制新冠病毒或肺部纤维化的药物中的应用 |
-
2021
- 2021-03-16 BR BR112022018504A patent/BR112022018504A2/pt not_active Application Discontinuation
- 2021-03-16 AU AU2021236622A patent/AU2021236622A1/en active Pending
- 2021-03-16 KR KR1020227035956A patent/KR20230012469A/ko not_active Ceased
- 2021-03-16 JP JP2022555887A patent/JP2023518390A/ja active Pending
- 2021-03-16 WO PCT/US2021/022538 patent/WO2021188520A1/en not_active Ceased
- 2021-03-16 CN CN202180025427.5A patent/CN115397410A/zh active Pending
- 2021-03-16 CA CA3172162A patent/CA3172162A1/en active Pending
- 2021-03-16 US US17/911,455 patent/US20230132782A1/en not_active Abandoned
- 2021-03-16 EP EP21771167.0A patent/EP4121040A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3172162A1 (en) | 2021-09-23 |
| WO2021188520A1 (en) | 2021-09-23 |
| US20230132782A1 (en) | 2023-05-04 |
| KR20230012469A (ko) | 2023-01-26 |
| CN115397410A (zh) | 2022-11-25 |
| JP2023518390A (ja) | 2023-05-01 |
| AU2021236622A1 (en) | 2022-10-13 |
| EP4121040A4 (en) | 2024-07-17 |
| EP4121040A1 (en) | 2023-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022004424A2 (pt) | Pró-fármacos antivirais e formulações dos mesmos | |
| BR112021022778A2 (pt) | Compostos e métodos para o tratamento de covid-19 | |
| BR112022026321A2 (pt) | Análogos de 1'-ciano nucleosídeo e usos dos mesmos | |
| BR112022010112A2 (pt) | Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica | |
| CO2019010295A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| CL2022002481A1 (es) | Compuestos antivirales y métodos para la administración de los mismos | |
| BR112022000503A2 (pt) | Compostos úteis para tratar infecções por vírus influenza | |
| CO2019013042A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| BR112023002951A2 (pt) | Compostos de fosfolipídio e usos destes | |
| CO2019010292A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| CO2019012035A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| BR112015028879A8 (pt) | compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos | |
| BR112017012327A8 (pt) | benzamidas substituídas por 1,3-tiazol-2-il. | |
| BR112016003348A2 (pt) | composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade efetiva de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica | |
| ECSP18073293A (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
| BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
| BR112015022096A8 (pt) | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos | |
| BR112015024552A2 (pt) | compostos de fórmula (a), composição farmacêutica, métodos para a preparação do composto e métodos de tratamento ou prevenção de infecções | |
| BR112019006802A2 (pt) | compostos e métodos para diagnóstico e tratamento de infecções virais | |
| BR112022018504A2 (pt) | Usos de uma composição | |
| BR112021025764A2 (pt) | Derivado de pirimidina que inibe o crescimento de células cancerígenas e uso medicinal do mesmo | |
| BR112022010798A2 (pt) | Derivado de metileno-naftaleno-éter de fenilisoxazolila, seu uso e composição farmacêutica compreendendo o mesmo | |
| AR128109A1 (es) | Spiros y análogos relacionados para inhibir yap / taz-tead | |
| BR112013032911A2 (pt) | leucotoxina e/d como um novo agente anti-inflamatório e microbicida | |
| BR112022019876A2 (pt) | Composições virucidas, composição farmacêutica, método de desinfecção e/ou esterilização, dispositivo e uso das composições virucidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |